These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14970516)

  • 1. Production and characterization of anti-cocaine catalytic antibodies.
    de Prada P; Landry DW
    Methods Mol Biol; 2004; 248():495-501. PubMed ID: 14970516
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment.
    Kuhar MJ; Carroll FI; Bharat N; Landry DW
    Synapse; 2001 Aug; 41(2):176-8. PubMed ID: 11400184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of single chain anti-cocaine catalytic antibodies.
    McKenzie KM; Mee JM; Rogers CJ; Hixon MS; Kaufmann GF; Janda KD
    J Mol Biol; 2007 Jan; 365(3):722-31. PubMed ID: 17084858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic antibodies and their applications.
    Hanson CV; Nishiyama Y; Paul S
    Curr Opin Biotechnol; 2005 Dec; 16(6):631-6. PubMed ID: 16243512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of anti-cocaine catalytic antibody from biodegradable polymer microspheres.
    Homayoun P; Mandal T; Landry D; Komiskey H
    J Pharm Pharmacol; 2003 Jul; 55(7):933-8. PubMed ID: 12906750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of inhibitory monoclonal antibodies. A critical step for producing anti-idiotypic catalytic antibodies.
    Avalle B; Friboulet A; Thomas D
    Ann N Y Acad Sci; 1998 Dec; 864():118-30. PubMed ID: 9928086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the catalysis of anti-cocaine catalytic antibody: competing reaction pathways and free energy barriers.
    Pan Y; Gao D; Zhan CG
    J Am Chem Soc; 2008 Apr; 130(15):5140-9. PubMed ID: 18341277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-catalyzed degradation of cocaine.
    Landry DW; Zhao K; Yang GX; Glickman M; Georgiadis TM
    Science; 1993 Mar; 259(5103):1899-901. PubMed ID: 8456315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting.
    Kim DS; Lee SH; Kim JS; Lee SC; Kwon MH; Kim YS
    Biochem Biophys Res Commun; 2009 Feb; 379(2):314-8. PubMed ID: 19103171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of monoclonal antibodies directed against cocaine and cocaethylene: potential new tools for immunotherapy.
    Danger Y; Devys A; Gadjou C; Galons H; Blanchard D; Folléa G
    Hybrid Hybridomics; 2004 Aug; 23(4):212-8. PubMed ID: 15319068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural convergence in the active sites of a family of catalytic antibodies.
    Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M
    Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes.
    Wagner J; Lerner RA; Barbas CF
    Science; 1995 Dec; 270(5243):1797-800. PubMed ID: 8525368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine catalytic antibodies: the primary importance of linker effects.
    Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD
    Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional mimicry between anti-Tendamistat antibodies and alpha-amylase.
    Gonçalves O; Dintinger T; Blanchard D; Tellier C
    J Immunol Methods; 2002 Nov; 269(1-2):29-37. PubMed ID: 12379350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyclonal catalytic anti-idiotypic antibodies with a beta-lactamase activity.
    Avalle B; Mistro D; Thomas D; Friboulet A
    Ann N Y Acad Sci; 1996 Oct; 799():172-5. PubMed ID: 8958088
    [No Abstract]   [Full Text] [Related]  

  • 17. Substrate-assisted antibody catalysis.
    Deng S; Bharat N; de Prada P; Landry DW
    Org Biomol Chem; 2004 Feb; 2(3):288-90. PubMed ID: 14747854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cocaine catalytic antibodies--a novel approach to the problem of addiction.
    Landry DW; Yang GX
    J Addict Dis; 1997; 16(3):1-17. PubMed ID: 9243335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved generation of catalytic antibodies by MRL/MPJ-lpr/lpr autoimmune mice.
    Takahashi N; Kakinuma H; Hamada K; Shimazaki K; Yamasaki Y; Matsushita H; Nishi Y
    J Immunol Methods; 2000 Feb; 235(1-2):113-20. PubMed ID: 10675763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of polyclonal catalytic antibodies against cocaine using transition state analogs of cocaine conjugated to diphtheria toxoid.
    Basmadjian GP; Singh S; Sastrodjojo B; Smith BT; Avor KS; Chang F; Mills SL; Seale TW
    Chem Pharm Bull (Tokyo); 1995 Nov; 43(11):1902-11. PubMed ID: 8575031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.